2m 2m 2m 2m 2m 2m 2m
CDT EQUITY (CDT)
NASDAQ
$0.24-$0.01 (-5.20%)
Price as of Sep 11, 2026 7:59 PM EDT- $3.4MMarket Cap
- -99.98%1-Year Change
- BiotechnologyIndustry
CDT EQUITY (CDT)
$0.24-$0.01 (-5.20%)
CDT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.25 | ||
Change | -$0.09 (-27.49%) | ||
Open | $0.26 | ||
High | $0.26 | ||
Low | $0.23 | ||
Previous Close | $0.34 | ||
Volume | 10,194,624 | ||
30-Day Average Volume | 2,842,517 | ||
1-Week Change | -60.01% | ||
1-Month Change | -91.55% | ||
1-Year Change | -99.98% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 13.7M | ||
Total Assets | $126.7M | ||
Market Cap | $3.4M | ||
Enterprise Value | $2.7M | ||
Period: QTR TTM FY | |||
Revenue | $341,000.00 | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$544,000.00 | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | -$20.4M | ||
EPS | -$87.10 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 8 | ||
P/B | N/A | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/20/2026 | ||
Earnings & Revenue